All About Multiple SclerosisThe latest MS News articlesEssays describing Multiple SclerosisMultiple Sclerosis Encyclopaedia/GlossaryA list of celebrities with Multiple SclerosisPersonal Experiences with MSOther MS resources on the WebSearch this siteAbout this site

IN-1 IgM

The Escherichia coli-derived Fab fragment of the IgM/kappa antibody IN-1 recognizes
                       and neutralizes myelin-associated inhibitors of neurite growth.

                       Bandtlow C, Schiweck W, Tai HH, Schwab ME, Skerra A

                       Institut fur Hirnforschung, Universitat Zurich, Switzerland.

                       A recombinant Fab fragment was prepared from the monoclonal IgM/kappa antibody IN-1, which neutralizes
                       central nervous system myelin-associated neurite growth inhibitors both in vitro and in vivo. The variable domain
                       gene sequences were amplified and cloned after cDNA synthesis from the hybridoma RNA. After insertion into
                       the tet promoter vector pASK85, which provided the constant domains of class IgG1/kappa, equipped with a
                       His6 tag, large amounts of the Fab fragment were produced in Escherichia coli by medium cell density
                       fermentation. The Fab fragment was purified to homogeneity by immobilized metal-affinity chromatography and
                       its biochemical activity was compared with the original IN-1 antibody. In an assay for neurite outgrowth and
                       fibroblast spreading, the Fab fragment showed a similar neutralizing effect on inhibitory substrate properties of
                       central nervous system myelin as the unpurified IgM, although an approximately tenfold higher concentration was
                       necessary. Immunoprecipitation experiments revealed a more selective antigen-binding behaviour for the Fab
                       fragment. The Fab fragment was also successfully applied for antigen detection in immunohistochemical analyses.
                       Therefore, the recombinant Fab fragment of IN-1 shows full functionality in vitro and appears to be well suited
                       for replacing the monoclonal IgM in investigations on fiber tract regeneration in vivo.


MS Glossary
All About Multiple Sclerosis